Ventilator-associated pneumonia by multidrug-resistant bacteria: Pathogen-specific risks versus care-related risks

Journal of Critical Care

Volumn 22, Issue 1, 2007, Pages 26-27

  Orhan Sungur, Mukadder ^a,b   Akça, Ozan ^a,b,c  

^a Outcomes Research Institute   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Acinetobacter; Multidrug resistant; Nosocomial; Pneumonia; Pseudomonas; Ventilator associated

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DNA DNA HYBRIDIZATION; EVIDENCE BASED PRACTICE; GRAM NEGATIVE INFECTION; HEALTH CARE ACCESS; HEALTH CARE FACILITIES AND SERVICES; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MULTIDRUG RESISTANCE; RISK BENEFIT ANALYSIS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 33947233695     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2006.09.002     Document Type: Note

References (19)

1. Euzéby J. List of prokaryotic names with standing in nomenclature-genus Acinetobacter. www.bacterio.cict.fr/a/acinetobacter.html [Accessed August 12, 2006]
2. Jain R., and Danziger L.H. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 38 (2004) 1449-1459
3. Fournier P.E., and Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42 (2006) 692-699
4. Murray C.K., and Hospenthal D.R. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 18 (2005) 502-506
5. Corbella X., Montero A., Pujol M., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38 (2000) 4086-4095
6. Rodriguez-Bano J., Cisneros J.M., Fernandez-Cuenca F., et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 25 (2004) 819-824
7. Landman D., Quale J.M., Mayorga D., et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162 (2002) 1515-1520
8. Garnacho J., Sole-Violan J., Sa-Borges M., et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 31 (2003) 2478-2482
9. Blot S., Vandewoude K., and Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29 (2003) 471-475
10. Medina J., et al. Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species. J Crit Care (2006)
11. Lortholary O., Fagon J.Y., Hoi A.B., et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20 (1995) 790-796
12. Fagon J.Y., Chastre J., Domart Y., et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 139 (1989) 877-884
13. Villers D., Espaze E., Coste-Burel M., et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 129 (1998) 182-189
14. Blot S., Vandewoude K., De Bacquer D., et al. Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 34 (2002) 1600-1606
15. Carmeli Y., Troillet N., Karchmer A.W., et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159 (1999) 1127-1132
16. Combes A., Luyt C.E., and Trouillet J.L. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia. Semin Respir Crit Care Med 27 (2006) 23-28
17. Akca O., Koltka K., Uzel S., et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 93 (2000) 638-645
18. Rello J. Bench-to-bedside review: therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care 9 (2005) 259-265
19. Ramirez J. Nosocomially-Acquired Pneumonia (NAP) Outcomes Performance Improvement Team Report (2006), University of Louisville, School of Medicine, Louisville (Ky)